Allena Pharmaceuticals to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
August 03, 2021 at 16:15 PM EDT
NEWTON, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that company management will participate in the upcoming 12th Annual Wedbush PacGrow Healthcare Conference on August 10th – August 11th, 2021.
Louis Brenner, M.D., Allena’s President and Chief Executive Officer, will participate in the Casino Re-nal Part 2 - Cysts and Stones panel discussion. Details for the panel discussion are below:
Management will also be available for 1x1 meetings on Tuesday, August 10th – Wednesday, August 11th, 2021.
About Allena Pharmaceuticals